Enhancement of lung levels of antibiotics by ambroxol and bromhexine-Reference-Cited by-同舟云学术

Enhancement of lung levels of antibiotics by ambroxol and bromhexine

Published:2019-02-07 Issue:3 Volume:15 Page:213-218
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Deretic Vojo¹^ORCID,Timmins Graham S.²

Affiliation:

1. Autophagy Inflammation and Metabolism Center, and Department of Molecular Genetics and Microbiology, University of New Mexico Health Sciences Center, Albuquerque, NM, USA

2. Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM, USA

Funder

National Institute of Allergy and Infectious Diseases

National Institute of General Medical Sciences

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2019.1578748

Reference34 articles.

1. Safety of ambroxol in the treatment of airway diseases in adult patients

2. Ambroxol Induces Autophagy and Potentiates Rifampin Antimycobacterial Activity

3. Pharmaceutical screen identifies novel target processes for activation of autophagy with a broad translational potential

4. Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing pulmonary delivery and immunomodulation of respiratory diseases through virus-mimicking nanoparticles;Journal of Controlled Release;2024-08

2. Bovine Respiratory Disease;Production Diseases in Farm Animals;2024

3. Approach to selecting mucoactive medications to treat cough in children;Meditsinskiy sovet = Medical Council;2023-10-30

4. Mucus Hypersecretion in Chronic Obstructive Pulmonary Disease and Its Treatment;Mediators of Inflammation;2023-07-06

5. Degradation kinetics and formation of regulated and emerging disinfection by-products during chlorination of two expectorants ambroxol and bromhexine;Water Research;2023-05